Latest Posts

- 15TH JANUARY 2026
- 0
Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of
- Community Pharmacy England News
- 14TH JANUARY 2026
- 0
Supporting you in 2026: Our work with Pharmacist Support
Alongside critical work making the financial case for the sector, Community Pharmacy England will be working with Pharmacist Support in 2026 to help support the wellbeing of pharmacists and their teams. The continuing fragility of pharmacy finances, alongside high workloads, stress, ongoing uncertainty and rising reports of patient abuse across England, take a real toll
- Community Pharmacy England News
- 14TH JANUARY 2026
- 0
From Pressure to Progress: Why Your Voice Matters in 2026
Note: This article was first published in The Pharmacist. By James Wood, Director of Member and LPC Support at Community Pharmacy England I hope you managed to take a little time over the festive season to recharge. For many, that break will have been short-lived, if indeed it happened, and the reality of another challenging
- Community Pharmacy England News
- 13TH JANUARY 2026
- 0
Discontinuation of Subutex® and Suboxone® tablets
Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies to order. Please note that if a prescriber has issued a branded prescription for any strength of Subutex®,
- Community Pharmacy England News
- 12TH JANUARY 2026
- 0
Cleen Ready-to-use enema Drug Tariff price adjustment – November and December 2025
The Department of Health and Social Care (DHSC) has confirmed that prescriptions for Cleen Ready-to-use 133ml enema (Sodium dihydrogen phosphate dihydrate 18.1% / Disodium hydrogen phosphate dodecahydrate 8% 133ml enema) dispensed in November and December 2025 will be correctly reimbursed based on its increased NHS list price which had not been reflected in the published
- Community Pharmacy England News

- 12TH JANUARY 2026
- 0
Medicine Supply Notification: Co-codamol 30mg/500mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-codamol 30mg/500mg tablets. MSN/2026/001 Tier 3 – High impact Date of issue: 12 January 2026 Co-codamol 30mg/500mg tablets will be in limited supply from early February until early June 2026. Paracetamol 500mg tablets remain available and can support a full uplift
- Community Pharmacy England News
- 12TH JANUARY 2026
- 0
Pharmacy pressures: tax rises are driving more closures across the country
Daily Express There have been media reports today in the Daily Express highlighting growing pharmacy pressures and closures across England and Wales. Figures from the Independent Pharmacies Association (IPA) indicate hundreds of pharmacies have closed, with warnings that recent tax and cost pressures are forcing many out of business. Rachel Reeves accused of pushing pharmacies
- Community Pharmacy England News
- 12TH JANUARY 2026
- 0
MHRA Drug Safety Update: Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs
The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment Report) were that it was necessary to strengthen these warnings in the product information and on packaging to better inform healthcare professionals and patients of these known risks. Advice for
- Community Pharmacy England News
- 6TH JANUARY 2026
- 0
FSA recall: SMA Infant and Follow‑On Formula (Nestlé)
Date issued: 5 January 2026 FSA Ref: FSA-PRIN-02-2026 Nestlé has issued a precautionary recall for several SMA infant and follow‑on formula products, due to potential contamination with cereulide toxin—a heat‑stable toxin produced by Bacillus cereus. Affected Products Pharmacy teams should review their stock for the following products and batch codes: SMA Advanced First Infant Milk
- Community Pharmacy England News
- 5TH JANUARY 2026
- 0
Advance payment timetable for 2026
Pharmacy owners should note that the next advance payment will be received on the 12th January 2026 (for activity completed in December 2025 and declared using the FP34C form on the Manage Your Service (MYS) portal  by the 6th January). The table below shows the advance payment dates for 2026. Dispensing Month Dec 25 Jan
- Community Pharmacy England News

Latest News